Cassia Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cassia Capital Partners's LLY Position: Q2 2026 in Review
Cassia Capital Partners reduced its Eli Lilly (LLY) stake by 0.31% in Q2 2026, selling an estimated $5.11K and leaving 1,603 shares worth $1.92M. The position accounts for 0.93% of the portfolio, ranked #18.
Cassia Capital Partners first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cassia Capital Partners held 1,603 shares of Eli Lilly worth $1.92M as of Q2 2026.
- Cassia Capital Partners sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
- Eli Lilly made up 0.93% of Cassia Capital Partners's portfolio in Q2 2026, its #18 holding.
- Cassia Capital Partners first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cassia Capital Partners's 13F filing for Q2 2026, filed 30 Jul 2026.